South Korea due to publish draft device regulations
This article was originally published in Clinica
South Korea's draft revised medical device regulations were due to be published at the beginning of December. This follows nearly two years of industry lobbying for changes to the new regulatory requirements announced in February 1994, which were considered extremely onerous and of doubtful necessity (see Clinica No 611, p 10). The South Korean authorities intend to canvass industry opinion on the revisions.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.